Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

FCF Payout Ratio: 26.92%

popular:market cap|pe ratio|revenue|price history|total return

Is the FCF payout ratio high or low?

The FCF payout ratio of 26.92% is in line with its 5-year average of 27.62%, around the middle of its 5-year range (14.14%–51.85%).

2.15% below its 12-month average of 27.51%.

Dividends Overview|Dividends per Share|Dividends CAGR|Payout Ratio|Dividend Yield
FCF Payout Ratio

DGX FCF Payout Ratio

26.92%

Rolling trailing-12-month FCF payout ratio sampled each quarter; raw quarterly payout is intentionally not charted.

+90.39% 5Y
DGX FCF Payout Ratio

DGX Average FCF Payout Ratio Chart

DGX FCF Payout Ratio

DGX Current vs Average FCF Payout Ratio Chart

DGX FCF Payout Ratio Metrics

FCF PAYOUT RATIO

26.92%

FCF PAYOUT RATIO AVG TTM

27.51%

FCF PAYOUT RATIO AVG 3Y

31.93%

FCF PAYOUT RATIO AVG 5Y

27.62%

FCF PAYOUT RATIO AVG 10Y

28.01%

FCF PAYOUT RATIO AVG 15Y

26.81%

FCF PAYOUT RATIO AVG 20Y

23.00%

CURRENT VS TTM AVG

-2.15%

CURRENT VS 3Y AVG

-15.68%

CURRENT VS 5Y AVG

-2.53%

CURRENT VS 10Y AVG

-3.89%

CURRENT VS 15Y AVG

+0.41%

CURRENT VS 20Y AVG

+17.05%

Payout Ratio Comparison

FCF Payout Ratio TTM

26.9%

Earnings Payout Ratio

36.8%

Dividend Yield

1.58%

FCF Yield

5.74%

Annual FCF Payout Ratio History

YearFree Cash FlowDividends PaidFCF Payout Ratio
2025$1.36B$353.00M26.0%
2024$909.00M$331.00M36.4%
2023$864.00M$314.00M36.3%
2022$1.31B$305.00M23.2%
2021$1.83B$309.00M16.9%
2020$1.59B$297.00M18.7%
2019$843.00M$286.00M33.9%
2018$817.00M$266.00M32.6%
2017$923.00M$247.00M26.8%
2016$776.00M$223.00M28.7%
2015$547.00M$212.00M38.8%
2014$630.00M$187.00M29.7%
2013$421.00M$185.00M43.9%
2012$1.00B$108.10M10.8%
2011$734.00M$64.70M8.8%
2010$912.60M$108.00M11.8%
2009$830.50M$110.20M13.3%
2008$850.40M$78.00M9.2%
2007$707.82M$77.33M10.9%
2006$758.47M$77.14M10.2%
2005$627.31M$69.67M11.1%
2004$622.65M$61.39M9.9%
2003$488.16M$00.0%
2002$441.18M$00.0%
2001$316.82M$8.95M2.8%
2000$253.00M$6.90M2.7%
1999($851.50M)$0.10MN/A (Loss)
1998$100.90M$0.10M0.1%
1997$129.50M$0.10M0.1%
1996($158.88M)$1.17MN/A (Loss)

Formula: FCF Payout Ratio TTM = trailing 4Q dividends paid / trailing 4Q free cash flow × 100

FCF payout and earnings payout:

  • FCF represents operating cash flow after capital expenditures
  • FCF payout compares dividends paid with free cash flow
  • FCF payout above 100% means dividends paid exceeded free cash flow for the period
  • Earnings payout compares dividends paid with net income

Reading the series: Use the chart and table to compare dividend payments with cash generation over time.

FCF Payout Ratio Formula & Definition

FCF Payout Ratio measures trailing dividends paid as a percentage of trailing free cash flow. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

FCF Payout Ratio FAQ

What is the FCF payout ratio for Quest Diagnostics Incorporated (DGX)?
The FCF payout ratio for DGX stock is 26.92%.
Is Quest Diagnostics Incorporated's FCF payout ratio high or low?
The FCF payout ratio of 26.92% is in line with its 5-year average of 27.62%, around the middle of its 5-year range (14.14%–51.85%).
What is the TTM average FCF payout ratio for Quest Diagnostics Incorporated (DGX)?
The TTM average FCF payout ratio for DGX stock is 27.51%.
What is the 3Y average FCF payout ratio for Quest Diagnostics Incorporated (DGX)?
The 3Y average FCF payout ratio for DGX stock is 31.93%.
What is the 5Y average FCF payout ratio for Quest Diagnostics Incorporated (DGX)?
The 5Y average FCF payout ratio for DGX stock is 27.62%.
What is the 10Y average FCF payout ratio for Quest Diagnostics Incorporated (DGX)?
The 10Y average FCF payout ratio for DGX stock is 28.01%.
What is the 15Y average FCF payout ratio for Quest Diagnostics Incorporated (DGX)?
The 15Y average FCF payout ratio for DGX stock is 26.81%.
What is the 20Y average FCF payout ratio for Quest Diagnostics Incorporated (DGX)?
The 20Y average FCF payout ratio for DGX stock is 23.00%.

DGX FCF Payout Ratio History

DATEFCF PAYOUT RATIO
2026-03-3126.92%
2025-12-3125.97%
2025-09-3024.91%
2025-06-3027.94%
2025-03-3131.82%
2024-12-3136.41%
2024-09-3031.96%
2024-06-3036.91%
2024-03-3133.69%
2023-12-3136.34%
2023-09-3051.85%
2023-06-3034.97%
2023-03-3135.30%
2022-12-3123.21%
2022-09-3020.97%
2022-06-3019.65%
2022-03-3119.23%
2021-12-3116.89%
2021-09-3016.40%
2021-06-3014.14%
2021-03-3114.56%
2020-12-3118.71%
2020-09-3021.17%
2020-06-3035.42%
2020-03-3136.59%
2019-12-3133.93%
2019-09-3034.90%
2019-06-3030.14%
2019-03-3129.53%
2018-12-3132.56%
2018-09-3028.34%
2018-06-3028.25%
2018-03-3128.08%
2017-12-3126.76%
2017-09-3028.09%
2017-06-3029.54%
2017-03-3127.58%
2016-12-3128.74%
2016-09-3028.57%
2016-06-3031.56%
2016-03-3133.85%
2015-12-3138.76%
2015-09-3035.27%
2015-06-3033.56%
2015-03-3131.48%
2014-12-3129.68%
2014-09-3033.22%
2014-06-3034.98%
2014-03-3141.01%
2013-12-3143.94%
2013-09-3027.71%
2013-06-3018.17%
2013-03-3114.83%
2012-12-3110.76%
2012-09-309.90%
2012-06-309.25%
2012-03-3110.01%
2011-12-318.81%
2011-09-3010.86%
2011-06-3011.37%
2011-03-319.73%
2010-12-319.04%
2010-09-308.95%
2010-06-309.44%
2010-03-3113.76%
2009-12-3113.28%
2009-09-3016.26%
2009-06-3014.74%
2009-03-3111.36%
2008-12-3113.04%
2008-09-309.27%
2008-06-3011.27%
2008-03-3110.93%
2007-12-3110.92%
2007-09-3011.52%
2007-06-3012.47%
2007-03-3111.72%
2006-12-3110.17%
2006-09-309.82%
2006-06-3010.54%
2006-03-318.96%
2005-12-3111.11%
2005-09-3011.27%
2005-06-309.92%
2005-03-3110.46%
2004-12-319.86%
2004-09-307.57%
2004-06-305.49%
2004-03-312.90%

Related Metrics

Dividends OverviewDividends per ShareDividends CAGRPayout RatioDividend Yield

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
www.questdiagnostics.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
View full financials